Indications for Use of Hepatitis B Vaccine, Based on Cost-Effectiveness Analysis
- 9 September 1982
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 307 (11), 644-652
- https://doi.org/10.1056/nejm198209093071103
Abstract
To formulate indications for the use of hepatitis B vaccine, we examined the cost effectiveness of three strategies: vaccinating everyone; screening everyone and vaccinating those without evidence of immunity; and neither vaccinating nor screening, but passively immunizing those with known exposure.This publication has 62 references indexed in Scilit:
- Abnormal serum transaminase levels in patients with hemophilia AArchives of Internal Medicine, 1982
- Transmission of Hepatitis B VirusSeminars in Liver Disease, 1981
- Toward the Control of Hepatitis BNew England Journal of Medicine, 1980
- Hepatitis B VaccineNew England Journal of Medicine, 1980
- Medical Intensive Care: Indications, Interventions, and OutcomesNew England Journal of Medicine, 1980
- Hepatitis b virus, hepatitis a virus and persistently elevated aminotransferases in hemophiliacsJournal of Medical Virology, 1980
- Hepatitis A and B: serologic survey of various population groupsThe American Journal of the Medical Sciences, 1978
- Chronic Liver Dysfunction in Multitransfused HemophiliacsTransfusion, 1977
- Hepatitis-B Surface Antigen (HBsAg) and Antibody (Anti-HBs) Prevalence Among Laboratory and Nonlaboratory Hospital PersonnelSouthern Medical Journal, 1977
- The Epidemiology of Hepatitis B in a Residential Institution for the Mentally Retarded*Australian and New Zealand Journal of Medicine, 1976